<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="sitemap-style.css"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml"><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1" /><lastmod>2024-07-25T09:51:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/registration</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/registration" /><lastmod>2024-07-05T14:01:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/opening-address-keynote-presentation-100-undruggable-targets-unlocked-through-parallel-mab-engineering</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/opening-address-keynote-presentation-100-undruggable-targets-unlocked-through-parallel-mab-engineering" /><lastmod>2024-07-05T14:09:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/designing-complexity-with-purpose-sharing-lessons-from-the-front-lines-of-bi-and-multi-specific-antibody-development</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/designing-complexity-with-purpose-sharing-lessons-from-the-front-lines-of-bi-and-multi-specific-antibody-development" /><lastmod>2026-07-31T15:49:22Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break" /><lastmod>2024-07-05T14:18:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break-1</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break-1" /><lastmod>2024-07-05T14:19:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/morning-refreshments</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/morning-refreshments" /><lastmod>2024-07-05T14:22:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/topic-tbc</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/topic-tbc" /><lastmod>2025-10-14T11:02:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/networking-lunch</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/networking-lunch" /><lastmod>2024-07-05T14:36:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break-2</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break-2" /><lastmod>2024-07-05T14:42:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break-3</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break-3" /><lastmod>2024-07-05T14:43:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/afternoon-refreshments</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/afternoon-refreshments" /><lastmod>2024-07-05T14:45:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/poster-presentation-from-disease-target-identification-to-de-novo-antibody-design</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/poster-presentation-from-disease-target-identification-to-de-novo-antibody-design" /><lastmod>2026-02-10T11:31:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/are-we-optimizing-the-wrong-molecules-re-thinking-lead-selection-for-next-generation-therapeutics</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/are-we-optimizing-the-wrong-molecules-re-thinking-lead-selection-for-next-generation-therapeutics" /><lastmod>2025-01-10T15:16:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/drinks-canape-reception</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/drinks-canape-reception" /><lastmod>2024-07-05T14:51:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/poster-presentation-from-adcs-to-novel-modalities-enabling-diverse-antibody-conjugates-with-ajicap</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/poster-presentation-from-adcs-to-novel-modalities-enabling-diverse-antibody-conjugates-with-ajicap" /><lastmod>2026-06-19T10:06:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/spotlight-presentation-advanced-analytical-solutions-for-antibodies-product-and-impurity-characterization</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/spotlight-presentation-advanced-analytical-solutions-for-antibodies-product-and-impurity-characterization" /><lastmod>2024-11-07T12:47:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/poster-presentation-rapid-generation-of-bispecific-antibodies-for-high-throughput-screening-with-spylock-technology</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/poster-presentation-rapid-generation-of-bispecific-antibodies-for-high-throughput-screening-with-spylock-technology" /><lastmod>2025-01-20T11:46:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/poster-presentation-redefining-the-limits-of-camelid-immunization-speed-diversity-and-drug-like-vhhs-against-challenging-target-classes</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/poster-presentation-redefining-the-limits-of-camelid-immunization-speed-diversity-and-drug-like-vhhs-against-challenging-target-classes" /><lastmod>2026-01-13T13:54:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/from-car-ts-to-t-cell-engagers-translating-early-learnings-beyond-oncology</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/from-car-ts-to-t-cell-engagers-translating-early-learnings-beyond-oncology" /><lastmod>2025-01-17T17:08:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/careful-selection-of-building-block-properties-and-compatibility-essential-to-boost-the-overall-success-of-multispecifics</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/careful-selection-of-building-block-properties-and-compatibility-essential-to-boost-the-overall-success-of-multispecifics" /><lastmod>2026-07-31T15:43:46Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/beyond-hit-count-designing-antibody-discovery-campaigns-that-preserve-functional-diversity</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/beyond-hit-count-designing-antibody-discovery-campaigns-that-preserve-functional-diversity" /><lastmod>2025-03-06T12:06:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/overcoming-developability-challenges-when-designing-next-gen-bi/multi-specifics</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/overcoming-developability-challenges-when-designing-next-gen-bi/multi-specifics" /><lastmod>2025-10-14T11:02:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/topic-tbc-1</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/topic-tbc-1" /><lastmod>2025-08-04T09:03:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/selecting-the-optimal-architecture-for-bi-and-multi-specific-antibodies</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/selecting-the-optimal-architecture-for-bi-and-multi-specific-antibodies" /><lastmod>2025-05-27T09:46:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/lead-identification-optimization-topic-new-approach-methodologies-for-immunogenicity-risk-assessment-and-functional-evaluation-of-drug-candidates</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/lead-identification-optimization-topic-new-approach-methodologies-for-immunogenicity-risk-assessment-and-functional-evaluation-of-drug-candidates" /><lastmod>2025-10-14T11:02:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/-poster-presentation-lead-identification-optimization-topic-4-day-sequence-to-data-accelerating-al-driven-protein-discovery-via-integrated-cell-free-workflow</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/-poster-presentation-lead-identification-optimization-topic-4-day-sequence-to-data-accelerating-al-driven-protein-discovery-via-integrated-cell-free-workflow" /><lastmod>2026-02-10T11:31:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/leveraging-ai-and-early-structural-insights-to-power-rational-antibody-lead-design-and-optimization</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/leveraging-ai-and-early-structural-insights-to-power-rational-antibody-lead-design-and-optimization" /><lastmod>2025-05-27T10:03:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/engineering-bispecific-adcs-how-to-select-target-pairs-format-conjugation-and-dar</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/engineering-bispecific-adcs-how-to-select-target-pairs-format-conjugation-and-dar" /><lastmod>2026-07-31T15:45:34Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/expanding-efficacy-while-maintaining-an-acceptable-therapeutic-index</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/expanding-efficacy-while-maintaining-an-acceptable-therapeutic-index" /><lastmod>2025-10-14T13:56:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/linker-selection-design-choice-or-default-choice</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/linker-selection-design-choice-or-default-choice" /><lastmod>2026-01-08T09:53:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/adc-payload-design-enhancing-cytotoxic-potency-while-reducing-off-target-toxicity</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/adc-payload-design-enhancing-cytotoxic-potency-while-reducing-off-target-toxicity" /><lastmod>2025-10-17T14:25:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/spotlight-presentation-accelerating-antibody-and-biologic-workflows-with-chemically-aware-macromolecule-registration</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/spotlight-presentation-accelerating-antibody-and-biologic-workflows-with-chemically-aware-macromolecule-registration" /><lastmod>2025-11-14T14:54:00Z</lastmod></url><url><loc>https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break-4</loc><xhtml:link rel="alternate" hreflang="en-GB" href="https://hub-xchange.com/antibody-therapeutics-xchange-new-jersey-2026-1/1-2-1-meetings-/-networking-break-4" /><lastmod>2026-07-29T09:57:00Z</lastmod></url></urlset>